NDC product
Docusate Sodium
NDC 81877-840 · Forreal Pharmaceuticals, LLC
Key facts
| Product NDC | 81877-840 |
|---|---|
| Proprietary name | Docusate Sodium |
| Nonproprietary name | Docusate Sodium |
| Substances | DOCUSATE SODIUM |
| Dosage form | CAPSULE |
| Route | ORAL |
| Labeler | Forreal Pharmaceuticals, LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing start | May 1, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: